Pulmonx (LUNG) Profit After Tax (2019 - 2025)
Pulmonx's (LUNG) quarterly Profit After Tax came in at -$14.0 million in Q3 2025, down 2587.88% year-on-year from $561000.0 in Q3 2024, and up 8.01% on a QoQ basis from -$15.2 million in Q2 2025.
Pulmonx (LUNG) Profit After Tax (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has 7 years of Profit After Tax data on file, last reported at -$14.0 million in Q3 2025.
- On a quarterly basis, Profit After Tax fell 2587.88% year-over-year to -$14.0 million in Q3 2025; TTM through Sep 2025 was -$691000.0, a 103.54% decrease from a year earlier, with the FY2024 full-year figure at -$527000.0, down 149.48% from the prior year.
- Profit After Tax for Q3 2025 stood at -$14.0 million, up from -$15.2 million in the prior quarter.
- Over the last five years, Profit After Tax for LUNG reached as high as $48.0 million in Q4 2023 and fell as low as -$58.6 million in Q4 2022.
- Historically, Profit After Tax has averaged -$10.8 million across 5 years, with a median of -$14.4 million in 2025.
- Across the five-year window, Profit After Tax plunged 21841.54% in 2022 and surged 181.93% in 2023, its largest moves.
- Year by year, Profit After Tax stood at -$48.5 million in 2021, then dropped by 20.79% to -$58.6 million in 2022, then jumped by 181.93% to $48.0 million in 2023, then decreased by 10.87% to $42.8 million in 2024, then plunged by 132.61% to -$14.0 million in 2025.
- Per Business Quant data, the three most recent Profit After Tax figures were -$14.0 million in Q3 2025, -$15.2 million in Q2 2025, and -$14.4 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 170.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Pulmonx | 49.94 Mn | -19.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -13.96 Mn |
| Jun 30, 2025 | -15.17 Mn |
| Mar 31, 2025 | -14.36 Mn |
| Dec 31, 2024 | 42.80 Mn |
| Sep 30, 2024 | 561,000.00 |
| Jun 30, 2024 | -15.33 Mn |
| Mar 31, 2024 | -13.75 Mn |
| Dec 31, 2023 | 48.02 Mn |
| Sep 30, 2023 | -14.91 Mn |
| Jun 30, 2023 | -16.20 Mn |
| Mar 31, 2023 | -15.86 Mn |
| Dec 31, 2022 | -58.61 Mn |
| Sep 30, 2022 | -14.13 Mn |
| Jun 30, 2022 | -14.64 Mn |
| Mar 31, 2022 | -15.83 Mn |
| Dec 31, 2021 | -48.52 Mn |
| Sep 30, 2021 | 65,000.00 |
| Jun 30, 2021 | -12.96 Mn |
| Mar 31, 2021 | -12.51 Mn |
| Dec 31, 2020 | -9.30 Mn |